93% of Consumers Are Health-Engaged — Is Your NPD Pipeline Keeping Up?

TL;DR:
Health-conscious eating is not a niche — it is the market. Mintel’s 2025 Better For You Eating Trends research shows that 93% of US consumers are either maintaining or increasing effort toward their diet. 41% are putting more effort in than last year. And this is not generational: 44% of Gen Z, 44% of Millennials, and 43% of Gen X are all increasing effort at nearly identical rates. For F&B manufacturers, this data eliminates the question of whether to invest in healthier product development. The only question is whether your product development infrastructure can innovate at the speed and scale the entire market now demands.

How Big Is the Health-Engaged Consumer Market for F&B Manufacturers?

The first instinct when reading health-trend data is to segment: which consumers care about health, and which do not? Mintel’s 2025 data makes that segmentation almost irrelevant. 93% of US consumers are either maintaining or actively increasing effort toward their diet. Only 7% report putting in less effort. This is not a trend to monitor — it is the baseline consumer expectation.

The growth signal is equally striking: 41% say they are putting more effort into their diet than last year, while 52% are maintaining their current level of effort. The market is not just large — it is actively expanding. And it is expanding across every demographic that matters to F&B manufacturers.

Generational data eliminates the assumption that health engagement is driven by any single cohort. 44% of Gen Z, 44% of Millennials, and 43% of Gen X are all increasing effort at statistically indistinguishable rates. Even among Baby Boomers, 36% are increasing effort. A product development strategy that targets “health-conscious Millennials” as a niche is targeting 93% of the market through a 44% lens. The opportunity is portfolio-wide, not segment-specific.

Parents are the most intensely health-engaged demographic: 48% of moms and 46% of dads are putting more effort into their diet, compared to 38% of women and 35% of men without children. Parents are not just more engaged — they are making purchasing decisions for entire households, amplifying the impact of their health preferences across multiple product categories.

Why Can’t Most F&B NPD Pipelines Keep Up with Health Demand?

When 93% of consumers are health-engaged, the product development challenge is not identifying a target market — it is serving the entire market simultaneously. Health demand is not one product line. It is a reformulation mandate across every category: snacks, beverages, dairy, bakery, prepared foods, sauces, and frozen. Each category has its own formulation constraints, regulatory requirements, and retail timelines.

The Mintel data reveals the breadth of what consumers expect. 55% are limiting certain foods and drinks (reformulation demand). 53% are focusing on protein (fortification demand). 51% are watching portions (packaging innovation demand). 40% are prioritizing fiber (functional ingredient demand). These are not niche requests — they are mainstream expectations that touch every SKU in a manufacturer’s portfolio.

Most F&B new product development pipelines were not designed for this scale of simultaneous innovation. They were designed for sequential projects: develop one product, validate it, launch it, then start the next. When the market demands parallel innovation across dozens of SKUs — reformulating for lower sugar while fortifying for protein while adjusting portions while updating labeling across multiple markets — the sequential pipeline becomes the bottleneck. The constraint is not R&D talent or consumer insight. It is the infrastructure that connects formulation, regulatory compliance, labeling, and packaging coordination into a workflow that can handle parallel execution.

What Does Portfolio-Wide Health Innovation Require from F&B Product Development?  

When health demand is universal, product development infrastructure must be universal too. The question for C-suite leadership is not whether to invest in healthier products — the 93% stat settles that. The question is whether the organization’s product lifecycle management explained infrastructure can support the scale of innovation the market requires. 

Portfolio-wide health innovation means managing reformulation, fortification, and new product development across multiple categories simultaneously. It means every formulation change automatically triggering nutritional recalculation, regulatory validation per market, and labeling updates. It means new product concepts moving from consumer insight to shelf-ready product in months, not years, because the reformulation imperative for F&B manufacturers is accelerating and GLP-1’s impact on food product development is adding protein density, fiber fortification, and portion control to an already complex agenda. 

The US dietary guidelines for Americans continue to emphasize nutrient-dense food choices across all demographics, reinforcing the consumer-driven demand that Mintel’s data quantifies. As food science and technology research from the Institute of Food Technologists documents, the complexity of formulating products that meet both consumer expectations and regulatory requirements is increasing, not simplifying. 

Companies like Barilla, Ocean Spray, and Perfetti Van Melle — managing complex product portfolios across global markets — have invested in PLM for food and beverage product development that connects formulation, compliance, and labeling in a single workflow. As PLM market analysis from CIMdata confirms, this integration is the infrastructure foundation for the speed and scale of innovation that consumer demand now requires. The 93% is not going back to 50%. The question is whether your product development infrastructure is built for a market where health is the baseline, not the exception.

Frequently Asked Questions 

93% of consumers are health-engaged. Is your product development infrastructure built for the whole market? 
See how PLM for food and beverage product development enables portfolio-wide health innovation — from reformulation to regulatory compliance to labeling — in a single workflow.

About Trace One

With more than 30 years of industry expertise, Trace One partners with over 9,000 brands across food and beverage, cosmetics, and chemicals to accelerate product development and turn regulatory complexity into a competitive advantage. Our AI-powered PLM platform, with regulatory intelligence spanning 170+ countries, supports the entire product manufacturing lifecycle — helping brands bring market-leading products to shelf faster and thrive in new markets. Learn more at traceone.com.